Medicine Information

Bextra and Vioxx Withdrawal Spurs Price Increase Among Rivals


The market for painkillers is huge. People don't like pain and inflammation, and last year Americans spent nearly $4 billion on just two of them - Vioxx and Bextra. Those two drugs, part of a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, were withdrawn from the market recently amid concerns that they can cause heart attacks and strokes. The loss of these two drugs to the marketplace is huge, as they were the two largest sellers in a fairly narrow field. COX-2 inhibitors differ from traditional non-steroidal anti-inflammatory drugs in that they inhibit production of the COX-2 enzyme that causes inflammation but do not interfere with COX-1, the enzyme that protects the stomach lining. Patients who use these drugs are thought to suffer less from internal discomfort and bleeding than those who took traditional anti-inflammatories, such as naproxen and ibuprofen.

With the withdrawal of these two blockbusters, patients with chronic pain, such as arthritis sufferers, are now going back to older painkillers, such as Mobic, Motrin, and Relafen. Since the more popular Vioxx and Bextra are no longer available, these older drugs are enjoying a resurgence in popularity, and sales are up across the board. So, it seems, are their prices. A recent study by a popular consumer publication shows that prices of some three dozen anti-inflammatory medications have gone up since Vioxx was withdrawn from the market in September 2004. The increases average about ten percent. Why have the prices of these older, established medications all gone up at once?

The answer, simply, is that the pharmaceutical companies have raised the prices because they can. The market for drugs is wildly competitive, and manufacturers are constantly seeking any advantage they can find in the marketplace. The sudden withdrawal of two of the most popular and profitable medications has provided a rare opportunity for manufacturers to increase both sales and prices at the same time, as the drug makers know that patients must switch to another medication. It's good for their stockholders, but bad for those who suffer from pain.

Will the high prices last? Probably not. Pricing of highly competitive medications tends to be volatile. The prices may stay up in the short term, but other medications may be introduced soon, or Bextra or Vioxx may be returned to the market. The introduction of other drugs will restore more competition to the market, and prices may drop once again. The market for painkilling drugs is a bit of a crazy one, and patients should simply exhibit some, well, patience.

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

China Medicine Corporation Awarded GSP Certification
MarketWatch - 35 minutes ago
("China Medicine" or "the Company"), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines ...


The G8 has rescinded its pledge to give medicine to people with ...
guardian.co.uk, UK - 6 hours ago
I came with a simple message from my daughter, Smilie: "Tell Tony Blair that I saw Dr David who gave me medicine. I am now feeling better and I can go back ...
An end to the AIDS epidemic? Study provides new reason for hope New York Daily News
AIDS epidemic can be eradicated in a decade: Study The Money Times
Med students launch AIDS awareness program Beaufort Gazette
Monsters and Critics.com - Asian Tribune
all 366 news articles


New Marketing Coaching and Consulting Firm for Physicians ...
MarketWatch - 6 minutes ago
"There are a growing number of physicians making the switch to concierge medicine, but they either don't know how to effectively convert their existing ...


Efforts to properly dispose of medicine increase
Detroit Free Press, United States - Nov 30, 2008
At evening's end, the community-based effort sent 300 pounds of prescription and over-the-counter medicines to an incinerator, rather than down a toilet, ...


Telegraph.co.uk

Drug firms 'block' cheap medicine
BBC News, UK - Nov 28, 2008
Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said. ...
EU report: Drug makers block market entry of competing medicines Xinhua
EU says drug industry delay tactics cost us €3bn Times Online
EU says drug firms blocked generics United Press International
euronews - TIME
all 333 news articles


Outskirts Press Announces See!, the Latest Highly-Anticipated ...
PR.com (press release), NY - 7 hours ago
The 6.14 x 9.21 paperback in the Medicine/ Health Care category is available worldwide on book retailer websites such as Amazon and Barnes & Noble for a ...


Combining Targeted Therapy Drugs May Treat Previously Resistant Tumors
Science Daily (press release) - 17 hours ago
In their Nature Medicine report, which is receiving early online release, investigators from Dana-Farber Cancer Institute (DFCI), Massachusetts General ...


Patients thinking outside the Rx
Albany Times Union, NY - 10 hours ago
While two-thirds of Americans older than age 50 use alternative medicine, most of them keep it to themselves, according to a survey conducted by NIH's ...


Doctors ditch drug samples to avoid influencing treatment
USA Today - 8 hours ago
In January, a study in the journal PLoS Medicine estimated that in 2004, drugmakers handed out free samples to US doctors with a retail value of nearly $16 ...


Current World News

Treat HIV like other diseases
Straits Times, Singapore - 16 hours ago
The problem is the high price of the medicine. The $1500 a month needed to pay for the cocktail of drugs many need is more than what three in four HIV ...
Progress on AIDS must include tests The Tennessean
World marks AIDS Day TheChronicleHerald.ca
No cure for society’s prejudice toward AIDS Hürriyet
The State Journal-Register - The Witness
all 66 news articles

Medicine - Google News

home | site map
© 2006